"Research use only" is not a legal disclaimer
Most grey-market peptide vendors label their products "for research use only" or "not for human consumption." This phrasing is a marketing convention that traces back to legitimate research-supply companies. The legal and regulatory reality is that it does not protect the seller from misbranding charges, the buyer from receiving an unregulated drug, or either party from harm.
Where the phrase comes from
"Research use only" (RUO) is a real category. Companies like Sigma-Aldrich, Cayman Chemical, and others sell thousands of compounds — including peptides, hormones, and drugs at varying purities — to academic and industrial research labs. The "research use only" label means:
- Not manufactured under cGMP for pharmaceutical use.
- Purity, identity, and impurity profile may not match FDA-approved drug specs.
- Not validated for clinical diagnostic or therapeutic use.
- Buyer is assumed to be a qualified researcher who understands the limitations.
For an actual research lab, the label is meaningful. The lab is using the compound in cell culture, animal studies, or analytical chemistry — not injecting it into themselves.
How grey-market vendors borrow the phrase
Vendors selling BPC-157, TB-500, GHK-Cu, and other unapproved peptides for human use typically label everything "research use only" or "not for human consumption." The intent is to suggest:
- The vendor is operating in the same legal space as Sigma-Aldrich.
- The buyer assumes responsibility by ordering.
- FDA enforcement doesn't apply because the product isn't marketed for human use.
None of these inferences is reliable.
What the FDA actually looks at
FDA enforcement around unapproved drugs evaluates a pattern of marketing, not just a single label. Specifically:
- Product presentation. Sold in injection-ready volumes (5 mg lyophilized vials with BAC water available) suggests human use.
- Customer base. Vendors selling primarily to individuals, not institutions, are clearly not in a research-supply business.
- Marketing language. Promotional content mentioning "results," "dosing protocols," or "before/after" effectively markets for human use regardless of the legal label.
- Site content. Forum partnerships, customer testimonials about effects, dosing guidance — all evidence the product is intended for human use.
A vendor that fails any of these tests is operating outside the RUO framework, regardless of what the label says.
What it doesn't protect
The seller
FDA has taken enforcement action against grey-market peptide sellers — warning letters, import alerts, seizures, criminal charges in extreme cases. The "research use only" label has not been a successful defense. A pattern of selling to individuals with marketing implying human use is treated as misbranding and distribution of an unapproved drug.
The buyer
Importing an unapproved drug, even for personal use, is technically illegal under federal law. FDA has discretion to seize personal shipments at customs; pursuit of buyers for criminal charges is rare but possible. Civil liability for harm from a product you self-administered is not affected by the seller's label.
The vendor's product quality
The label doesn't make the product cleaner, the COA more reliable, or the supply chain more accountable. A "research use only" vial of BPC-157 from a grey-market vendor has the same quality risks as a pharmaceutical product but with no regulatory oversight.
The legitimate-research-supply distinction
You can tell the difference between a real research supplier and a grey-market vendor in plain language:
| Property | Real research supplier (Sigma, Cayman) | Grey-market peptide vendor |
|---|---|---|
| Catalog | Thousands of compounds, almost none injectable | ~50 peptides, all injection-ready |
| Pricing | $200–$2,000 per mg often; many are research-grade pricy | $30–$80 per 5 mg vial |
| Customers | Institutions with research accounts | Individuals, anonymous shipping |
| Marketing | Catalog only; no "results" content | Heavy promotional content, testimonials, "stacks" |
| COA | Detailed analytical data per lot | Often a generic template not tied to lot |
What this means for buyers
- The label is not a protection. Treat the product as what it is: an unregulated injection of unknown identity and purity from a non-pharmaceutical supplier.
- Quality varies enormously. Real per-lot COA, third-party HPLC verification, and a track record matter much more than the label.
- Legal exposure is the buyer's. If something goes wrong (contamination, identity error), the legal recourse against an unidentified vendor is limited.
- Legitimate alternatives exist for FDA-approved drugs. If you need semaglutide or tirzepatide, a 503A pharmacy with patient-specific compounding is on much firmer ground than a grey-market vendor.
FAQ
Can the FDA actually come after individuals?
Rarely. FDA enforcement priorities focus on sellers, especially those with significant volume or fraudulent marketing. Individual buyers are usually not pursued criminally; civil consequences from product harm are the larger risk.
Is buying from a real research supplier (Sigma, Cayman) safer?
Different problem set. Their products are real and analytically characterized, but typically not in a form ready for injection (purity is research-grade, not pharmaceutical-grade; no sterility validation). Drawing and injecting from a Sigma vial is still self-administration of an unapproved drug.
What if a 503A pharmacy labels a compounded peptide "research use only"?
A 503A pharmacy isn't in the research-supply business. If they're labeling compounds RUO, they're probably outside their scope. Real 503A compounding is for a specific patient with a specific prescription, not a research designation.
Does importing from a non-US vendor change anything?
Doesn't make it better. Imports are subject to FDA customs review and personal-use import alerts. Many international peptide vendors ship discreetly, which makes the package easier to seize, not harder.
Related reading
Document the source of every vial
Peptide Protocol stores supply-chain notes for every vial — pharmacy, lot, label phrasing, COA — so a quality question has a clean answer.
Get the iPhone app →Informational and educational only. Not medical advice. Consult a licensed clinician before starting, changing, or stopping any peptide protocol. Mentions of investigational, compounded, or research-use peptides are for informational purposes; many such substances are not FDA-approved for human use.